ACAD
ACADIA Pharmaceuticals Inc.
$24.53
+$0.11(+0.45%)
76
Overall
70
Value
83
Tech
--
Quality
Market Cap
$4.12B
Volume
1.74M
52W Range
$13.40 - $26.65
Target Price
$30.21
EPS Estimates Overview
| Current Quarter | $0.14 | Next Quarter | $0.13 |
| Current Year | $0.52 | Next Year | $0.78 |
| QoQ Growth | -7.1% | YoY Growth | +50.0% |
| 3Y EPS CAGR | +48.9% | Target Price | $30.21 |
| Consensus | Buy | Upside | +23.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $24.53 | +0.5% | 1.74M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW